27.01.2017 • Topics

Ferak Berlin Receives GMP Certification

Thomas Gruendemann, CEO and managing director, Ferak
Thomas Gruendemann, CEO and managing director, Ferak

Berlin, Germany-based provider of contract research & development and custom manufacturing services, Ferak, has received GMP certification by the Berlin State Office for Health and Social Affairs (LAGeSo) for one of its Active Pharmaceutical Ingredients (API). The GMP certificate that has been obtained by help of the Administrative Court of Berlin is immediately available upon request. Prior to the allocation of the certificate an independent GMP expert authorized by the German Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel - BfArM) confirmed full EU-GMP Part II compliance of the manufacturing process and equipment. Further API certificates will follow, the company reports.

“I am more than proud to say that the whole team of Ferak has been working hard to achieve this highest quality standard in the chemical/pharmaceutical industry”, says CEO and managing director Thomas Gruendemann. “The combination of our scientific expertise with both a detailed documentation system and the latest production and analytical equipment is the key to the high purity of our APIs. A clear GMP aim and a zero defect supply chain history with all of our pharmaceutical customers have lead us to this level of excellence which meets exactly our mission statement The Art of Making Purity”, Gruendemann concludes.

Company

Ferak Berlin GmbH

Lahnstr. 34
12055 Berlin
Germany

Company contact







Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read